You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
大华继显:予平安好医生(1833.HK)“买入”评级 目标价90港元
格隆汇 04-07 16:02

大华继显昨日发研报称,平安好医生是医疗咨询中游戏规则改变者,凭借强大的内部医疗团队和人工智能技术,平安好医生在中国在线医疗咨询服务中排名第一,看好其在线医疗咨询市场的领导地位。公司以其独特的效率,每天远程处理72.9万次咨询。截至2019年,平安好医生拥有6690万MAU和30万MPU的庞大用户群,通过会员套餐、消费者医疗服务和一家健康购物中心实现盈利。该行预计,由于互联网医疗服务的采用、用户数量的增长和社会医疗保险覆盖面的扩大,OMS业务将继续强劲增长。

该行还称,平安好医生拥有独特的分销渠道以及高效的用户获取。平安集团拥有超过1500万的大病保险客户,有潜力进一步交叉销售和追加销售平安好医生的产品和服务。此外,平安好医生与福州卫计委合作建立和服务一个互联网医院平台,连接37个市、县级医院和100多个地方基层医疗机构。平安好医生将提供在线咨询、处方流通、医疗管理、数据监控和后台管理等服务。这将提升其品牌形象,亦能进一步渗透互联网医疗服务。

大华继显预计平安好医生在2020-22财年的收入将达到35%的年复合增长率,这得益于快速增长的会员和进一步的医院渗透。平安好医生的目标是在2021年底达到收支平衡,继续提高运作效率。该行予平安好医生 “买入”评级,目标价90港元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account